Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial

Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 and no longer shows Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, which appears to be a minor backend/software update with no visible changes to study content or layout. (To avoid being alerted by small changes, set an alert condition by clicking below.)
    Difference
    0.1%
    Check dated 2026-02-04T23:42:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Show glossary is now displayed; new metadata labels include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T19:59:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision identifiers updated to v3.3.4; previous v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:45:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A dedicated Locations section lists Arizona (Mayo Clinic, Scottsdale) for the study, replacing the old 'Arizona Locations' label. The HHS Vulnerability Disclosure link has been removed, and the page revision is now v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:32.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updates the page from v3.2.0. There are no substantive changes to study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:56.000Z thumbnail image

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.